Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant.
Miyaji KT, Infante V, Picone CM, Dillner J, Kann H, Eklund C, Levi JE, de Oliveira ACS, Lara AN, Kawakami LS, Tacla M, Castanheira CP, Mayaud P, Sartori AMC. Miyaji KT, et al. Among authors: kann h. Front Cell Infect Microbiol. 2024 Nov 4;14:1452916. doi: 10.3389/fcimb.2024.1452916. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39559707 Free PMC article. Clinical Trial.
Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil.
Miyaji KT, Infante V, Picone CM, Levi JE, Oliveira ACS, Lara AN, Tacla M, Dillner J, Kann H, Eklund C, Castanheira CP, Mayaud P, Sartori AMC; Study group on HPV vaccine in immunosuppressed persons. Miyaji KT, et al. Among authors: kann h. PLoS One. 2022 Jan 20;17(1):e0262724. doi: 10.1371/journal.pone.0262724. eCollection 2022. PLoS One. 2022. PMID: 35051227 Free PMC article.
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
Gray P, Kann H, Pimenoff VN, Eriksson T, Luostarinen T, Vänskä S, Surcel HM, Faust H, Dillner J, Lehtinen M. Gray P, et al. Among authors: kann h. PLoS Med. 2021 Jun 7;18(6):e1003588. doi: 10.1371/journal.pmed.1003588. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34097688 Free PMC article.
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
Mariz FC, Gray P, Bender N, Eriksson T, Kann H, Apter D, Paavonen J, Pajunen E, Prager KM, Sehr P, Surcel HM, Waterboer T, Müller M, Pawlita M, Lehtinen M. Mariz FC, et al. Among authors: kann h. Lancet Infect Dis. 2021 Oct;21(10):1458-1468. doi: 10.1016/S1473-3099(20)30873-2. Epub 2021 May 31. Lancet Infect Dis. 2021. PMID: 34081923 Clinical Trial.
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.
Gray P, Kann H, Pimenoff VN, Adhikari I, Eriksson T, Surcel HM, Vänskä S, Dillner J, Faust H, Lehtinen M. Gray P, et al. Among authors: kann h. Int J Cancer. 2020 Dec 15;147(12):3511-3522. doi: 10.1002/ijc.33169. Epub 2020 Jul 7. Int J Cancer. 2020. PMID: 32574384 Clinical Trial.
44 results